Ista Pharmaceuticals (Products Now Under Bausch + Lomb, Which Was Acquired By Valeant)

Ista Pharmaceuticals (Products Now Under Bausch + Lomb, Which Was Acquired By Valeant) company information, Employees & Contact Information

Updated June 2026

Quick answer

Ista Pharmaceuticals (Products Now Under Bausch + Lomb, Which Was Acquired By Valeant) is a Pharmaceutical Manufacturing company and founded in 2000. It has approximately 168 employees on record. Contact data was last refreshed in June 2026. Find Ista Pharmaceuticals (Products Now Under Bausch + Lomb, Which Was Acquired By Valeant)'s verified employee emails, phone numbers, headquarters address, and key decision makers below.

ISTA Pharmaceuticals, Inc, was a rapidly growing specialty pharmaceutical company developing, marketing and selling products in the U.S. and Puerto Rico. It was the fourth largest branded prescription eye care business in the U.S. and had an emerging allergy drug franchise. Its products treated ocular inflammation and pain, glaucoma, dry eye and ocular allergies. It had a U.S. sales force of more than 165 representatives calling on ophthalmologists, optometrists and allergists. The four key products included: • BROMDAY™ (bromfenac ophthalmic solution) 0.09% for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract extractions • BEPREVE® (bepotastine besilate ophthalmic solution) 1.5% for the treatment of ocular itching associated with allergic conjunctivitis • ISTALOL® (timolol maleate ophthalmic solution) 0.05% for the treatment of glaucoma • VITRASE® (hyaluronidase injection) ovine, 200 USP units/ml for use as a spreading agent In June of 2012, ISTA was acquired by Bausch + Lomb and now operates under the Pharmaceutical business of Bausch + Lomb. In July of 2013, Bausch + Lomb was acquired by Valeant.

Company Details

Employees
168
Founded
2000
Address
50 Technology Drive, Irvine,ca 92618,united States
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Irvine, CA
Looking for a particular Ista Pharmaceuticals (Products Now Under Bausch + Lomb, Which Was Acquired By Valeant) employee's phone or email?

Ista Pharmaceuticals (Products Now Under Bausch + Lomb, Which Was Acquired By Valeant) Questions

News

Bausch and Lomb Lawsuit (enVista Intraocular Lense Recall) - Oberheiden P.C.

Bausch and Lomb Lawsuit (enVista Intraocular Lense Recall) Oberheiden P.C.

Historic Tudor Mansion Built for Bausch & Lomb Heiress Hits the Market in Upstate New York for $3.2 Million - Realtor.com

Historic Tudor Mansion Built for Bausch & Lomb Heiress Hits the Market in Upstate New York for $3.2 Million Realtor.com

Bausch and Lomb's dealmaking CEO Brent Saunders: No deal for company is imminent - Yahoo Finance

Bausch and Lomb's dealmaking CEO Brent Saunders: No deal for company is imminent Yahoo Finance

Bausch & Lomb Recalls Implantable Eye Lenses After Reports of Complications - TODAY.com

Bausch & Lomb Recalls Implantable Eye Lenses After Reports of Complications TODAY.com

Bausch + Lomb identifies issue in enVista platform, returns product to market - Ophthalmology Times

Bausch + Lomb identifies issue in enVista platform, returns product to market Ophthalmology Times

Bausch + Lomb to remain public amid deal negotiations of sale - Optometry Times

Bausch + Lomb to remain public amid deal negotiations of sale Optometry Times

BAUSCH & LOMB ALERT: Bragar Eagel & Squire, P.C. is - GlobeNewswire

BAUSCH & LOMB ALERT: Bragar Eagel & Squire, P.C. is GlobeNewswire

Bausch & Lomb amends CEO contract and performance stock unit terms - Investing.com

Bausch & Lomb amends CEO contract and performance stock unit terms Investing.com

Major Board Shake-up: Icahn Representatives Exit Bausch + Lomb Board as Ownership Falls Below Threshold - Stock Titan

Major Board Shake-up: Icahn Representatives Exit Bausch + Lomb Board as Ownership Falls Below Threshold Stock Titan

Bausch & Lomb Escapes Class Claims in Suit Over Eye Supplement - Bloomberg Law News

Bausch & Lomb Escapes Class Claims in Suit Over Eye Supplement Bloomberg Law News

After M&A rumors sparked stock volatility, Bausch + Lomb confirms it's exploring a sale - Fierce Pharma

After M&A rumors sparked stock volatility, Bausch + Lomb confirms it's exploring a sale Fierce Pharma

FDA Warning & Voluntary Recall Information: enVista Intraocular Lenses (Bausch & Lomb) - Oberheiden P.C.

FDA Warning & Voluntary Recall Information: enVista Intraocular Lenses (Bausch & Lomb) Oberheiden P.C.

Lupin launches copy of Bausch & Lomb’s ophthalmic drug - The Hindu

Lupin launches copy of Bausch & Lomb’s ophthalmic drug The Hindu

Bausch + Lomb voluntarily recalls select enVista IOLs - Optometry Times

Bausch + Lomb voluntarily recalls select enVista IOLs Optometry Times

Marketing Mix of Bausch and Lomb and 4Ps (Updated 2025) - Marketing91

Marketing Mix of Bausch and Lomb and 4Ps (Updated 2025) Marketing91

Bausch + Lomb Announces Scientific Data On Bausch + Lomb INFUSE™ Silicone Hydrogel Daily Disposable Contact Lenses To Be Presented At The Virtual Global Specialty Lens Symposium - PR Newswire

Bausch + Lomb Announces Scientific Data On Bausch + Lomb INFUSE™ Silicone Hydrogel Daily Disposable Contact Lenses To Be Presented At The Virtual Global Specialty Lens Symposium PR Newswire

TPG and Blackstone team up to bid for eyecare group Bausch + Lomb - Financial Times

TPG and Blackstone team up to bid for eyecare group Bausch + Lomb Financial Times

Bausch + Lomb valued at $6.5 billion after stock ticks up in NYSE debut - Reuters

Bausch + Lomb valued at $6.5 billion after stock ticks up in NYSE debut Reuters

Bausch + Lomb to spin off eye care business - 13wham.com

Bausch + Lomb to spin off eye care business 13wham.com

Bausch & Lomb Earnings: Gains From Eye Care and Pharma Record Strong Sales and Offset Supply Issues - Morningstar

Bausch & Lomb Earnings: Gains From Eye Care and Pharma Record Strong Sales and Offset Supply Issues Morningstar

Bausch + Lomb Expands Parameters for Bausch + Lomb ULTRA® Multifocal for Astigmatism Contact Lenses - PR Newswire

Bausch + Lomb Expands Parameters for Bausch + Lomb ULTRA® Multifocal for Astigmatism Contact Lenses PR Newswire

Bausch + Lomb Recalls Project Watson Eyelid Wipes for Dogs Due to Risk of Exposure to Bacteria and Fungi - U.S. Consumer Product Safety Commission (.gov)

Bausch + Lomb Recalls Project Watson Eyelid Wipes for Dogs Due to Risk of Exposure to Bacteria and Fungi U.S. Consumer Product Safety Commission (.gov)

Bausch + Lomb rolls out new surgical planning software for Eyetelligence platform - Ophthalmology Times

Bausch + Lomb rolls out new surgical planning software for Eyetelligence platform Ophthalmology Times

FDA clears new Bausch + Lomb contact lens rewetting drop - Healio

FDA clears new Bausch + Lomb contact lens rewetting drop Healio

Bausch + Lomb’s uncertain future - Rochester Beacon

Bausch + Lomb’s uncertain future Rochester Beacon

Bausch + Lomb countering contact lens dryness with new drops, multifocal lens - Healio

Bausch + Lomb countering contact lens dryness with new drops, multifocal lens Healio

Bausch + Lomb Introduces Project Watson™ Health Care Products for Dogs - PR Newswire

Bausch + Lomb Introduces Project Watson™ Health Care Products for Dogs PR Newswire

Bausch + Lomb and Sanoculis Announce Strategic Agreements Designed to Address Unmet Needs in Glaucoma - PR Newswire

Bausch + Lomb and Sanoculis Announce Strategic Agreements Designed to Address Unmet Needs in Glaucoma PR Newswire

Bausch + Lomb Receives 510(k) Clearance from FDA for Biotrue® Hydration Boost Contact Lens Rehydrating Drops - PR Newswire

Bausch + Lomb Receives 510(k) Clearance from FDA for Biotrue® Hydration Boost Contact Lens Rehydrating Drops PR Newswire

FDA approves Bausch + Lomb’s enVista Envy range of IOLs - Ophthalmology Times

FDA approves Bausch + Lomb’s enVista Envy range of IOLs Ophthalmology Times

Bausch and Lomb: What's going on in Rochester? - Democrat and Chronicle

Bausch and Lomb: What's going on in Rochester? Democrat and Chronicle

Bausch + Lomb Announces the U.S. Launch of Biotrue® Hydration Plus Multi-Purpose Solution - PR Newswire

Bausch + Lomb Announces the U.S. Launch of Biotrue® Hydration Plus Multi-Purpose Solution PR Newswire

Bausch and Lomb to expand contact lens manufacturing facilities in Rochester, Ireland - Democrat and Chronicle

Bausch and Lomb to expand contact lens manufacturing facilities in Rochester, Ireland Democrat and Chronicle

Bausch + Lomb and Novaliq Announce U.S. FDA Filing Acceptance for Investigational Treatment NOV03 (Perfluorohexyloctane) - PR Newswire

Bausch + Lomb and Novaliq Announce U.S. FDA Filing Acceptance for Investigational Treatment NOV03 (Perfluorohexyloctane) PR Newswire

Bausch + Lomb Receives Health Canada Approval of LUMIFY® Redness Reliever Eye Drops - PR Newswire

Bausch + Lomb Receives Health Canada Approval of LUMIFY® Redness Reliever Eye Drops PR Newswire

BLOG: Trukera finds a new home: Maker of tear osmolarity test acquired by Bausch + Lomb - Healio

BLOG: Trukera finds a new home: Maker of tear osmolarity test acquired by Bausch + Lomb Healio

Bausch + Lomb announces acquisition of the Blink OTC line of eye drops - Optometry Times

Bausch + Lomb announces acquisition of the Blink OTC line of eye drops Optometry Times

BAUSCH + LOMB CORPORATION LAUNCHES AS A PUBLICLY TRADED COMPANY - MultiVu

BAUSCH + LOMB CORPORATION LAUNCHES AS A PUBLICLY TRADED COMPANY MultiVu

Emergent BioSolutions taps former Bausch and Lomb chief as next CEO - The Business Journals

Emergent BioSolutions taps former Bausch and Lomb chief as next CEO The Business Journals

Bausch + Lomb Launches the #LUMIFYEyeDance Challenge on TikTok - PR Newswire

Bausch + Lomb Launches the #LUMIFYEyeDance Challenge on TikTok PR Newswire

Bausch + Lomb Announces 2024 Annual Meeting of Shareholder Results - The AI Journal

Bausch + Lomb Announces 2024 Annual Meeting of Shareholder Results The AI Journal

Bausch + Lomb Launches Alaway® Preservative Free Antihistamine Eye Drops - PR Newswire

Bausch + Lomb Launches Alaway® Preservative Free Antihistamine Eye Drops PR Newswire

Bausch + Lomb #LUMIFYEyeDance Challenge Wins 2022 Public Relations and Marketing Excellence Award for External Campaign of the Year from Business Intelligence Group - PR Newswire

Bausch + Lomb #LUMIFYEyeDance Challenge Wins 2022 Public Relations and Marketing Excellence Award for External Campaign of the Year from Business Intelligence Group PR Newswire

FDA Approves Bausch + Lomb Alaway® Preservative Free (Ketotifen Fumarate) Ophthalmic Solution, 0.035% - PR Newswire

FDA Approves Bausch + Lomb Alaway® Preservative Free (Ketotifen Fumarate) Ophthalmic Solution, 0.035% PR Newswire

Bausch + Lomb Launches Innovative Bausch + Lomb INFUSE™ Silicone Hydrogel (SiHy) Daily Disposable Contact Lenses - PR Newswire

Bausch + Lomb Launches Innovative Bausch + Lomb INFUSE™ Silicone Hydrogel (SiHy) Daily Disposable Contact Lenses PR Newswire

Bausch + Lomb Will Release First-Quarter 2024 Financial Results on May 1 - The AI Journal

Bausch + Lomb Will Release First-Quarter 2024 Financial Results on May 1 The AI Journal

I Tried These Innovative New Eye Drops and They Made My Eyes Look Brighter Than Ever - Allure

I Tried These Innovative New Eye Drops and They Made My Eyes Look Brighter Than Ever Allure

Bausch Health Will Expand Contact Lens Manufacturing Facilities In Rochester, NY And Waterford, Ireland - PR Newswire

Bausch Health Will Expand Contact Lens Manufacturing Facilities In Rochester, NY And Waterford, Ireland PR Newswire

Bausch + Lomb Introduces SimplifEYE™ IOL Delivery System For enVista® Toric And Monofocal Preloaded Intraocular Lenses - PR Newswire

Bausch + Lomb Introduces SimplifEYE™ IOL Delivery System For enVista® Toric And Monofocal Preloaded Intraocular Lenses PR Newswire

Bausch & Lomb settles 600 eye fungus lawsuits - ABC News - Breaking News, Latest News and Videos

Bausch & Lomb settles 600 eye fungus lawsuits ABC News - Breaking News, Latest News and Videos

Bausch & Lomb Settles Suits Over Eye Fungus Linked to Lens Solution - FindLaw

Bausch & Lomb Settles Suits Over Eye Fungus Linked to Lens Solution FindLaw

Bausch Health Licenses Novaliq's NOV03 Investigational Treatment For Dry Eye Disease Associated With Meibomian Gland Dysfunction - PR Newswire

Bausch Health Licenses Novaliq's NOV03 Investigational Treatment For Dry Eye Disease Associated With Meibomian Gland Dysfunction PR Newswire

Valeant, searching for cash, nears $2B sale of its Bausch & Lomb surgery business - Fierce Pharma

Valeant, searching for cash, nears $2B sale of its Bausch & Lomb surgery business Fierce Pharma

InWith Puts Smart Tech In Bausch And Lomb Lenses - Forbes

InWith Puts Smart Tech In Bausch And Lomb Lenses Forbes

Bausch & Lomb to Be Sold to Private Equity Firm - Medical Device and Diagnostic industry

Bausch & Lomb to Be Sold to Private Equity Firm Medical Device and Diagnostic industry

Bausch Health To Acquire Option To Purchase All Ophthalmology Assets Of Allegro Ophthalmics - PR Newswire

Bausch Health To Acquire Option To Purchase All Ophthalmology Assets Of Allegro Ophthalmics PR Newswire

Bausch + Lomb Introduces Enhanced PreserVision® AREDS 2 Formula Mini Soft Gels with OCUSorb™ - Business Wire

Bausch + Lomb Introduces Enhanced PreserVision® AREDS 2 Formula Mini Soft Gels with OCUSorb™ Business Wire

Bausch + Lomb Introduces PreserVision® AREDS 2 Formula Minigel Eye Vitamins - PR Newswire

Bausch + Lomb Introduces PreserVision® AREDS 2 Formula Minigel Eye Vitamins PR Newswire

Bausch & Lomb Sues Competition Over Copycat Formulation and 'Confusingly Similar' Product Name - Law.com

Bausch & Lomb Sues Competition Over Copycat Formulation and 'Confusingly Similar' Product Name Law.com

Fred Hassan of Bausch & Lomb, on Managers as Ambassadors (Published 2013) - The New York Times

Fred Hassan of Bausch & Lomb, on Managers as Ambassadors (Published 2013) The New York Times

Bausch + Lomb Introduces enVista® Toric MX60ET Intraocular Lens With StableFlex™ Technology - PR Newswire

Bausch + Lomb Introduces enVista® Toric MX60ET Intraocular Lens With StableFlex™ Technology PR Newswire

Bausch Health Announces VYZULTA® (Latanoprostene Bunod Ophthalmic Solution), 0.024%, is Now Approved In Seven Countries - PR Newswire

Bausch Health Announces VYZULTA® (Latanoprostene Bunod Ophthalmic Solution), 0.024%, is Now Approved In Seven Countries PR Newswire

Eye product concern slams Bausch & Lomb - NBC News

Eye product concern slams Bausch & Lomb NBC News

B+L recalling Muro 128 eye ointment - Democrat and Chronicle

B+L recalling Muro 128 eye ointment Democrat and Chronicle

Bausch & Lomb Accepts $4.5 Billion Takeover Bid (Published 2007) - The New York Times

Bausch & Lomb Accepts $4.5 Billion Takeover Bid (Published 2007) The New York Times

Bausch & Lomb Introduces New Ribbed Contacts For Extra Pleasure - The Onion

Bausch & Lomb Introduces New Ribbed Contacts For Extra Pleasure The Onion

Valeant confirms $9B acquisition of Bausch & Lomb - MassDevice

Valeant confirms $9B acquisition of Bausch & Lomb MassDevice

Bausch + Lomb Launches Biotrue™ ONEday Contact Lenses Made From Breakthrough HyperGel™ Material - PR Newswire

Bausch + Lomb Launches Biotrue™ ONEday Contact Lenses Made From Breakthrough HyperGel™ Material PR Newswire

Bausch & Lomb Solution Recall Exposes Risks for Eye Infections - The Wall Street Journal

Bausch & Lomb Solution Recall Exposes Risks for Eye Infections The Wall Street Journal

Marketing Strategy of Bausch and Lomb – Bausch and Lomb Marketing Strategy - Marketing91

Marketing Strategy of Bausch and Lomb – Bausch and Lomb Marketing Strategy Marketing91

From Asia to America, How Bausch's Crisis Grew (Published 2006) - The New York Times

From Asia to America, How Bausch's Crisis Grew (Published 2006) The New York Times

Bausch & Lomb agrees to buyout - Sarasota Herald-Tribune

Bausch & Lomb agrees to buyout Sarasota Herald-Tribune

Tesco recalls contact lens solution over 'burning' fears - BBC

Tesco recalls contact lens solution over 'burning' fears BBC

Top 10 Eyewear Companies | Shows Consistent Growth - Market.us Media

Top 10 Eyewear Companies | Shows Consistent Growth Market.us Media

Bausch & Lomb Removes Lens Solution - CBS News

Bausch & Lomb Removes Lens Solution CBS News

Annul Bausch & Lomb Doctrine for Both 'B' and 'C' Reorgs, Urges KPMG - Tax Notes

Annul Bausch & Lomb Doctrine for Both 'B' and 'C' Reorgs, Urges KPMG Tax Notes

Valeant Pharma buys PE owned Bausch & Lomb in $8.7bn deal - Financier Worldwide

Valeant Pharma buys PE owned Bausch & Lomb in $8.7bn deal Financier Worldwide

Strength in the SWOT Analysis of Bausch and Lomb : - Marketing91

Strength in the SWOT Analysis of Bausch and Lomb : Marketing91

Bausch & Lomb to be acquired by private equity firm - MetroWest Daily News

Bausch & Lomb to be acquired by private equity firm MetroWest Daily News

Bausch and Lomb PreserVision Eye Vitamin Recall: Choking Hazard - AboutLawsuits.com

Bausch and Lomb PreserVision Eye Vitamin Recall: Choking Hazard AboutLawsuits.com

Bausch & Lomb to invest €90m and create 130 jobs at Waterford plant - The Irish Times

Bausch & Lomb to invest €90m and create 130 jobs at Waterford plant The Irish Times

Bausch & Lomb Sells Unit - CBS News

Bausch & Lomb Sells Unit CBS News

COMPANY REPORTS; S.E.C. Starts Bausch & Lomb Inquiry (Published 1995) - The New York Times

COMPANY REPORTS; S.E.C. Starts Bausch & Lomb Inquiry (Published 1995) The New York Times

Bausch & Lomb, Executives Settle Charges With SEC - The Wall Street Journal

Bausch & Lomb, Executives Settle Charges With SEC The Wall Street Journal

Bausch Chief to Leave Soon; An Interim Leader Is Named (Published 1995) - The New York Times

Bausch Chief to Leave Soon; An Interim Leader Is Named (Published 1995) The New York Times

Bausch & Lomb calls media pitch in China - Campaign Asia

Bausch & Lomb calls media pitch in China Campaign Asia

Recall of specific lots of Bausch & Lomb Ophtaxia Eye Wash (with photos) - info.gov.hk

Recall of specific lots of Bausch & Lomb Ophtaxia Eye Wash (with photos) info.gov.hk

Bausch & Lomb optimistic of 10 to 11% growth in India - financialexpress.com

Bausch & Lomb optimistic of 10 to 11% growth in India financialexpress.com

New Bausch & Lomb Waterford facility officially opens - RTE.ie

New Bausch & Lomb Waterford facility officially opens RTE.ie

Delhi HC sets aside AO passed against Bausch and Lomb for violation of natural justice principles| SCC Times - SCC Online

Delhi HC sets aside AO passed against Bausch and Lomb for violation of natural justice principles| SCC Times SCC Online

Top Ista Pharmaceuticals (Products Now Under Bausch + Lomb, Which Was Acquired By Valeant) Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant